Skip to content
10-K

Annual Report

Merck & Co., Inc. MRK

0001628280-25-007732

← back to feed
Filed
Feb 25, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jan 31, 2025 2.53B sh
Long Term Debt FY 2024 · Dec 31, 2023 $33.68B
Short Term Debt FY 2024 · Dec 31, 2023 $1.37B
Cash And Equivalents FY 2024 · Dec 31, 2023 $6.84B
Stockholders Equity FY 2024 · Dec 31, 2023 $37.58B
Current Liabilities FY 2024 · Dec 31, 2023 $25.69B
Current Assets FY 2024 · Dec 31, 2023 $32.17B
Total Assets FY 2024 · Dec 31, 2023 $106.68B
Shares Diluted FY 2024 · Dec 31, 2022 2.54B sh
Stock Repurchased FY 2024 · Dec 31, 2022 $0
Dividends Paid FY 2024 · Dec 31, 2022 $7.01B
Capex FY 2024 · Dec 31, 2022 $4.39B
Operating Cash Flow FY 2024 · Dec 31, 2022 $19.1B
Eps Diluted FY 2024 · Dec 31, 2022 $5.71
Eps Basic FY 2024 · Dec 31, 2022 $5.73
Sga Expense FY 2024 · Dec 31, 2022 $10.04B
Rd Expense FY 2024 · Dec 31, 2022 $13.55B
Net Income FY 2024 · Dec 31, 2022 $14.52B
Cost Of Revenue FY 2024 · Dec 31, 2022 $17.41B
Revenue FY 2024 · Dec 31, 2022 $59.28B